Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 10,401–10,420 of 17,974 drug recalls

Drug Recall Terminated Historical recordClass II

BevaDex (bevacizumab) 0.06mL Prefilled 32 g (1.25mg/1mg) Syringes, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659 (877) BELLA.

by Bella Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility.
Recall initiated
August 15, 2017
Reported by FDA
September 20, 2017
Distribution
Nationwide within USA

View recall →

Drug Recall Terminated Historical recordClass II

Bevacizumab Prefilled 30g and 31 gram 1.25mg/0.05mL Syringes, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.

by Bella Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility.
Recall initiated
August 15, 2017
Reported by FDA
September 20, 2017
Distribution
Nationwide within USA

View recall →

Drug Recall Terminated Historical recordClass II

Fluorescein Sodium, 5mL vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.

by Bella Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility.
Recall initiated
August 15, 2017
Reported by FDA
September 20, 2017
Distribution
Nationwide within USA

View recall →

Drug Recall Terminated Historical recordClass II

Sodium Bicarbonate 8.4%, 10 mL vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.

by Bella Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility.
Recall initiated
August 15, 2017
Reported by FDA
September 20, 2017
Distribution
Nationwide within USA

View recall →

Drug Recall Terminated Historical recordClass II

Phenylephrine2.5%/Tropicamide 1% Ophthalmic Solution, 15mL bottle, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.

by Bella Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility.
Recall initiated
August 15, 2017
Reported by FDA
September 20, 2017
Distribution
Nationwide within USA

View recall →

Drug Recall Terminated Historical recordClass II

Lidocaine Ophthalmic Gel 3.5%, 15mL bottles, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659,1(877) BELLA.

by Bella Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility.
Recall initiated
August 15, 2017
Reported by FDA
September 20, 2017
Distribution
Nationwide within USA

View recall →

Drug Recall Terminated Historical recordClass II

MIC 25/50/50, 30mL vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.

by Bella Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility.
Recall initiated
August 15, 2017
Reported by FDA
September 20, 2017
Distribution
Nationwide within USA

View recall →

Drug Recall Terminated Historical recordClass II

L-Glutamine 100mg, 30 mL vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.

by Bella Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility.
Recall initiated
August 15, 2017
Reported by FDA
September 20, 2017
Distribution
Nationwide within USA

View recall →

Drug Recall Terminated Historical recordClass II

Magnesium Chloride 200mg, 30m L vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.

by Bella Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility.
Recall initiated
August 15, 2017
Reported by FDA
September 20, 2017
Distribution
Nationwide within USA

View recall →

Drug Recall Terminated Historical recordClass II

Methylcobalamin 10mg, (10mg/ml), 30 mL vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.

by Bella Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility.
Recall initiated
August 15, 2017
Reported by FDA
September 20, 2017
Distribution
Nationwide within USA

View recall →

Drug Recall Terminated Historical recordClass II

B-Complex, 30 mL vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659,1 (877) BELLA.

by Bella Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility.
Recall initiated
August 15, 2017
Reported by FDA
September 20, 2017
Distribution
Nationwide within USA

View recall →

Drug Recall Terminated Historical recordClass II

Calcium chloride 10%, 10 mL vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.

by Bella Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility.
Recall initiated
August 15, 2017
Reported by FDA
September 20, 2017
Distribution
Nationwide within USA

View recall →

Drug Recall Terminated Historical recordClass II

G.A.C 25/100/250mg, 30 mL Vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.

by Bella Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility.
Recall initiated
August 15, 2017
Reported by FDA
September 20, 2017
Distribution
Nationwide within USA

View recall →

Drug Recall Terminated Historical recordClass II

Mannitol 20%, 10 mL vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.

by Bella Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility.
Recall initiated
August 15, 2017
Reported by FDA
September 20, 2017
Distribution
Nationwide within USA

View recall →

Drug Recall Terminated Historical recordClass II

Methylcobalamin 10mg, (1mg/ml), 30 mL vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.

by Bella Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility.
Recall initiated
August 15, 2017
Reported by FDA
September 20, 2017
Distribution
Nationwide within USA

View recall →

Drug Recall Terminated Historical recordClass II

PF-Glutathione 200mg/ml, 30 mL vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659 1 (877) BELLA.

by Bella Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility.
Recall initiated
August 15, 2017
Reported by FDA
September 20, 2017
Distribution
Nationwide within USA

View recall →

Drug Recall Terminated Historical recordClass I

Super Panther 7K Capsules 1250 mg blend, a) 1 count blister cards shipped in boxes of 30 (UPC# 6015577513247); and b) 6 count bottles (UPC# 601577513209), Distributed by SX Power CO., Brooklyn, NY

by Chiavna Saffron LLC

Reason
Marketed without an Approved NDA/ANDA;FDA analysis found product to be tainted with sildendafil and tadalafil
Recall initiated
July 21, 2017
Reported by FDA
September 20, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

New Kopi Jantan Tradisional Natural Herbs Coffee, packaged in 13 gram red packets, and each box contains 25 packets, Made in Malaysia, USA Distributor: Bestherbscoffee LLC (USA), Email: bestherbscoffee@yahoo.com

by BESTHERBS COFFEE LLC

Reason
Marketed without an approved NDA/ANDA: presence of undeclared desmethyl carbodenafil and undeclared milk.
Recall initiated
July 17, 2017
Reported by FDA
September 20, 2017
Distribution
Recalling firm only distributed to 2 consignees in TX; however recalling firm reported that product is then distributed U.S. nationwide to consumers via individuals or internet

View recall →

Drug Recall Terminated Historical recordClass I

ANDROPHARM M1 ALPHA (Methyl-1-Etiocholenolol-Epietiocholanollone 20 mg) capsule, packaged in 60-count bottle, Amazon.com, UPC 6 42125 50292 4

by Andropharm, LLC

Reason
Marketed without an approved NDA/ANDA: product label states it contains anabolic steroids.
Recall initiated
June 6, 2017
Reported by FDA
September 20, 2017
Distribution
Florida

View recall →

Drug Recall Terminated Historical recordClass I

ANDROPHARM STEN Z (2, 17a-Dimethyl-17b-hydroxy-5a-androst-1-en-3-one 10mg and 17b-hydroxy-2a, 17b-dimethyl-5a-androstan-3-one azine 10 mg) capsule, packaged in 60-count bottle, Andropharm.com, UPC: 6 42125 50294 8

by Andropharm, LLC

Reason
Marketed without an approved NDA/ANDA: product label states it contains anabolic steroids.
Recall initiated
June 6, 2017
Reported by FDA
September 20, 2017
Distribution
Florida

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.